Astrana Health, Inc.
ASTH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,034,540 | $1,386,661 | $1,144,163 | $773,915 |
| % Growth | 46.7% | 21.2% | 47.8% | – |
| Cost of Goods Sold | $1,763,152 | $1,171,703 | $944,685 | $596,142 |
| Gross Profit | $271,388 | $214,958 | $199,478 | $177,773 |
| % Margin | 13.3% | 15.5% | 17.4% | 23% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $154,111 | $112,597 | $77,670 | $62,077 |
| SG&A Expenses | $154,111 | $112,597 | $77,670 | $62,077 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $27,927 | $17,748 | $17,543 | $17,517 |
| Operating Expenses | $182,038 | $130,345 | $95,213 | $79,594 |
| Operating Income | $89,350 | $84,613 | $104,265 | $98,179 |
| % Margin | 4.4% | 6.1% | 9.1% | 12.7% |
| Other Income/Exp. Net | -$8,532 | $5,225 | -$17,649 | -$20,431 |
| Pre-Tax Income | $80,818 | $89,838 | $86,616 | $77,748 |
| Tax Expense | $30,886 | $31,989 | $40,875 | $31,693 |
| Net Income | $43,149 | $60,717 | $45,171 | $68,923 |
| % Margin | 2.1% | 4.4% | 3.9% | 8.9% |
| EPS | 0.91 | 1.3 | 1 | 1.57 |
| % Growth | -30% | 30% | -36.3% | – |
| EPS Diluted | 0.9 | 1.29 | 0.99 | 1.52 |
| Weighted Avg Shares Out | 47,687 | 46,705 | 44,971 | 43,829 |
| Weighted Avg Shares Out Dil | 48,224 | 47,067 | 45,602 | 45,403 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14,508 | $14,208 | $1,976 | $1,571 |
| Interest Expense | $33,097 | $16,102 | $7,920 | $5,394 |
| Depreciation & Amortization | $27,927 | $17,748 | $17,543 | $17,517 |
| EBITDA | $141,842 | $123,688 | $112,079 | $100,659 |
| % Margin | 7% | 8.9% | 9.8% | 13% |